
About InterpretOmics
InterpretOmics is a Healthcare company based in Bengaluru (India) founded in 2009 by Amrith Prasad and Archana Prahlad. Cloud-based software is provided for genome data analysis and interpretation. InterpretOmics has raised $1.92 million across 2 funding rounds from investors including Amarante Shipping, Somaprasad Muttael Prabhakaran and Prashant Priya. The company has 56 employees. InterpretOmics was last valued at $7.33 million in January 2017. Its Indian entity Interpretomics India Private Limited reported revenue of βΉ1.20 Cr. InterpretOmics offers products and services including ELISA Kits, Recombinant Proteins, and Expression Vectors. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Diversified.
Company details
InterpretOmics is an integrated genomics company providing genome-scale data analysis and interpretation product and services. The company utilizes public and proprietary databases to analyze data and interpret results. Its enterprise level genomics data analysis platform iOMICS allows researchers to analyze DNA and identify diagnostic markers that indicate disease. Omnia is a platform which provides users access to genetic data sets across a board range of disease indications. The company has also introduced GeneComplete is an NGS-based genetic test to confirm or determine the presence of disease in an individual, suspected of having a disease. It is also working on Preimplantation genetic screening (PGS) - a microarray-based powerful genetic test that may be performed on embryos during IVF treatment to screen for numerical chromosomal abnormalities and Hotspot Cancer Mutation Screening. The company also offers genetic counseling services under the umbrella of AlphaLife using genetic and biochemical tests. It has processed about 35 TB of genomics data over 40 projects for clients including Delaware State University (DSU) and AIIMS. Singapore-based shipping company, Amarante is an investor in the company.
- Headquarters Bengaluru, India
- Employees 56
- Founders Amrith Prasad, Archana Prahlad
- Stage Minicorn
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website interpretomics.co
- Social LinkedIn X Facebook
- Legal Name Interpretomics India Private Limited
- Date of Incorporation 05 Dec, 2007
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹1.20 Cr
FY 2016 · +52% YoY
- Net Loss-₹5.37 Cr
FY 2016 · -446% margin
- EBITDA-₹4.60 Cr
FY 2016 · -382% margin
- Total Equity Funding$1.92M (USD)
in 2 rounds
- Latest Funding Round$293.14K (USD), Seed
Jan 2017
- InvestorsAmarante Shipping
& 2 more
- Employee Count56
Associated legal entities of InterpretOmics
InterpretOmics operates through Interpretomics India Private Limited (strike off). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2016) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Interpretomics India Private Limited CIN U73100KA2007PTC044578 | Strike Off | 05 Dec 2007 | Bangalore, Karnataka | ₹1.2 Cr | 56 | 5 | View details |
Products & Services of InterpretOmics
InterpretOmics offers a comprehensive portfolio of products and services, including ELISA Kits, Recombinant Proteins, and Expression Vectors.
Kits for antigen detection in molecular research
Proteins for cloning and expression in biology
Vectors for rapid DNA cloning and protein purification
Funding Insights of InterpretOmics
InterpretOmics has successfully raised a total of $1.92M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $293.14 thousand completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.92M
- Total Rounds 2
- Last Round Seed β $293,140
- First Round $1.63M
(Aug 2013)
- Investors Count 3
All 2 funding rounds of InterpretOmics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2017 | $293,140 | Seed | $7.33M | Amarante Shipping | |
| Aug 2013 | $1.63M | Seed | $8M | Amarante Shipping |
| Date | Valuation | Stage |
|---|---|---|
| Jan 2017 | $7.33M | β’β’β’β’β’β’β’β’ |
| Aug 2013 | $8M | β’β’β’β’β’β’β’β’ |
Last known valuation $7.33M (Jan 2017). 3 investors in total: 1 institutional and 2 angel.
Investors in InterpretOmics
InterpretOmics has secured backing from 3 investors, including institutional and angel investors. Prominent investors backing the company include Amarante Shipping, Somaprasad Muttael Prabhakaran and Prashant Priya.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Global provider of bulk cargo shipping, trading, and vessel operations services. | amarante.com.sg | Singapore, Singapore | ||
SM Somaprasad Muttael Prabhakaran | unknown_a0da2eab52bc4a99b | |||
PP Prashant Priya | unknown_32d1ecfdc7404aa08 |
Investor details for InterpretOmics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Interpretomics India Private Limited (InterpretOmics)
Interpretomics India Private Limited is the primary company behind InterpretOmics. The board of Interpretomics India Private Limited currently have 5 directors; the longest-serving is Prahalad Haldhoderi Achutharao, appointed in 2007. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Prahalad Haldhoderi Achutharao DIN 01804791 | Managing Director | 05 Dec 2007 | 18 yrs 11 mo | Interpretomics India Private Limited |
| Amrith Prasad DIN 02220047 | Director | 01 Jul 2013 | 13 yrs 4 mo | Interpretomics India Private Limited |
| Somaprasad Muttael Prabhakaran DIN 02217575 | Director | 01 Jul 2013 | 13 yrs 4 mo | Interpretomics India Private Limited |
| Jamshed Dara Parakh DIN 06872142 | Director | 23 Jul 2014 | 12 yrs 3 mo | Interpretomics India Private Limited |
| Prashant Priya DIN 03094896 | Director | 23 Jul 2014 | 12 yrs 3 mo | Interpretomics India Private Limited |
People of InterpretOmics
2 people are tracked at InterpretOmics (2 in leadership); the tracked headcount is 56.
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
Archana Prahlad | Co-Founder | Leadership |
Complete people profiles for InterpretOmics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of InterpretOmics
Figures of Interpretomics India Private Limited, the primary company behind InterpretOmics, for FY 2016. Revenue was ₹1.20 Cr (+52% year on year). Net loss was -₹5.37 Cr (-446% margin). EBITDA was -₹4.60 Cr (-382% margin).
- ₹1.20 CrRevenue · FY 2016 · +52% YoY
- -₹5.37 CrNet loss · -446% margin
- -₹4.60 CrEBITDA · -382% margin
- ₹1.17 CrPaid-up capital
- 56Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Interpretomics India Private Limited are on its company page.
Detailed financial statements for InterpretOmics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of InterpretOmics
4 dated milestones of InterpretOmics across 8 years, from founding to its latest funding, stage changes and deals.
- Founded InterpretOmics is founded.
- Funding First funding round of $1.6M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $293K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Interpretomics
Complete news archive for InterpretOmics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about InterpretOmics
InterpretOmics was founded in 2009 and raised its 1st funding round 4 years after it was founded.
InterpretOmics is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
InterpretOmics is a funded company, having raised a total of $1.92M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.63M, raised on Aug 2013.
InterpretOmics has 56 employees.
The primary company behind InterpretOmics, Interpretomics India Private Limited, reported revenue of βΉ1.20 Cr for FY 2016, up 52% year on year.
InterpretOmics is an integrated genomics company providing genome-scale data analysis and interpretation product and services. The company utilizes public and proprietary databases to analyze data and interpret results. Its enterprise level genomics data analysis platform iOMICS allows researchers to analyze DNA and identify diagnostic markers that indicate disease. Omnia is a platform which provides users access to genetic data sets across a board range of disease indications. The company has also introduced GeneComplete is an NGS-based genetic test to confirm or determine the presence of disease in an individual, suspected of having a disease. It is also working on Preimplantation genetic screening (PGS) - a microarray-based powerful genetic test that may be performed on embryos during IVF treatment to screen for numerical chromosomal abnormalities and Hotspot Cancer Mutation Screening. The company also offers genetic counseling services under the umbrella of AlphaLife using genetic and biochemical tests. It has processed about 35 TB of genomics data over 40 projects for clients including Delaware State University (DSU) and AIIMS. Singapore-based shipping company, Amarante is an investor in the company.
InterpretOmics offers ELISA Kits, Recombinant Proteins, and Expression Vectors.
InterpretOmics has 3 investors. Key investors include Amarante Shipping, Somaprasad Muttael Prabhakaran, and Prashant Priya.
The valuation of InterpretOmics is $7.33M as of Jan 2017.
InterpretOmics operates through Interpretomics India Private Limited.
The legal entities of InterpretOmics currently have 5 directors, including Jamshed Dara Parakh, Prahalad Haldhoderi Achutharao, Prashant Priya and others.
